No. |
Product Name |
CAS No. |
Spec |
Price |
|
| A-2096 |
Hesperadin ≥99% |
422513-13-1 |
|
|
| A-1948 |
HIF Phd Inhibitor 4 ≥98% |
1227946-51-1 |
|
|
| A-2034 |
HIF-2 inhibitor 2(Compound 2) ≥100% |
1422955-31-4 |
|
|
| A-2021 |
HL 010183 ≥99% |
N.A. |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1643 |
HLI 373 ≥98% |
N.A. |
|
|
| A-1616 |
HMR 1031 ≥98% |
479203-71-9 |
|
|
| A-1757 |
HMR 1098(HMR 1883 sodium salt) ≥98% |
261717-22-0 |
|
|
| A-1687 |
(±)-E-Homocamptothecin(dl-hCPT;BN 80245) ≥99% |
186668-40-6 |
|
|
| A-1890 |
HSF1A ≥99% |
1196723-93-9 |
|
|
| A-1650 |
HTI 286(SPA 110;Taltobulin) ≥99% |
228266-40-8 |
|
|
| A-1440 |
HU 308 ≥98% |
256934-39-1 |
|
|
| A-1996 |
6-Hydroxybuspirone HCl(BMS 528215;6OHB;6-OH-Bu) ≥98% |
125481-61-0 |
|
|
| A-1997 |
(R)-6-Hydroxybuspirone HCl(BMS 442608 HCl) ≥99% |
N.A. |
|
|
| A-1998 |
(S)-6-Hydroxybuspirone HCl(BMS 442606 HCl) ≥99% |
N.A. |
|
|
| A-1013 |
(R)-(+)-7-Hydroxy-DPAT HBr((R)-7-OH-DPAT) ≥98% |
1021878-34-1 |
|
|
| A-1016 |
(R)-(+)-8-Hydroxy-DPAT HBr ≥98% |
78095-19-9 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1007 |
(R)-5-Hydroxy-DPAT HBr((R)-5-OH-DPAT) ≥98% |
182210-73-7 |
|
|
| A-1010 |
(R)-6-Hydroxy-DPAT HBr((R)-6-OH-DPAT) ≥98% |
502508-84-1 |
|
|
| A-1014 |
(S)-(-)-7-Hydroxy-DPAT HBr((S)-7-OH-DPAT) ≥98% |
82730-73-2 |
|
|
| A-1017 |
(S)-(-)-8-Hydroxy-DPAT HBr((S)-(-)-8-OH-DPAT) ≥98% |
78095-20-2 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
